Author: United States. General Accounting OfficePublisher:
ISBN:
Category : Advertising
Languages : en
Pages : 40
Book Description
Prescription Drugs
Author: United States. General Accounting OfficePublisher:
ISBN:
Category : Advertising
Languages : en
Pages : 40
Book Description
Prescription Drugs
Author: United States. General Accounting OfficePublisher:
ISBN:
Category : Advertising
Languages : en
Pages : 24
Book Description
Prescription Drug Advertising to Consumers
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and InvestigationsPublisher:
ISBN:
Category : Advertising
Languages : en
Pages : 276
Book Description
the impact of direct-to-consumer drug advertising on seniors health and health care costs
Author: Publisher: DIANE Publishing
ISBN: 1422333035
Category :
Languages : en
Pages : 128
Book Description
Selling Sickness
Author: Ray MoynihanPublisher: Greystone Books
ISBN: 1926706684
Category : Health & Fitness
Languages : en
Pages : 171
Book Description
In this hard-hitting indictment of the pharmaceutical industry, Ray Moynihan and Allan Cassels show how drug companies are systematically using their dominating influence in the world of medical science, drug companies are working to widen the very boundaries that define illness. Mild problems are redefined as serious illness, and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. Selling Sickness reveals how expanding the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt national healthcare systems all over the world. This Canadian edition includes an introduction placing the issue in a Canadian context and describing why Canadians should be concerned about the problem.
Direct-to-consumer Advertising of Prescription Drugs
Author: United States. Congress. Senate. Special Committee on AgingPublisher:
ISBN:
Category : Advertising
Languages : en
Pages : 168
Book Description
The Impact of Direct-to-consumer Drug Advertising on Seniors' Health and Health Care Costs
Author: United States. Congress. Senate. Special Committee on AgingPublisher:
ISBN:
Category : Direct-to-consumer prescription drug advertising
Languages : en
Pages : 128
Book Description
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Reducing Race Differences in Direct-to-Consumer Pharmaceutical Advertising
Author: Stephany De SciscioloPublisher: Rowman & Littlefield
ISBN: 1498574173
Category : Social Science
Languages : en
Pages : 141
Book Description
Reducing health disparities by increasing access to health information is a national health policy priority. Evidence exists that direct-to-consumer pharmaceutical advertising (DTCA) is effective in educating consumers about health issues. However, racial disparities exist in such advertising. In 2009, the Food and Drug Administration (FDA) issued a report that included recommendations for enhancing the ability of DTCA to reach disadvantaged populations, including racial and ethnic minorities. Reducing Race Differences in Direct to Consumer Pharmaceutical Advertising compares the pharmaceutical advertisements placed in five popular women’s magazines published prior to and following the 2009 FDA report to assess the impact of these recommendations on the content and appearance of advertisements placed in magazines of differing racial orientation. From a health policy perspective, the results are disappointing. The FDA recommendations had no impact on the frequency or content of the DTCA appearing in White-oriented versus Black-oriented magazines. In fact, far fewer drugs used to treat life-threatening conditions were advertised in Black-oriented magazines after the 2009 FDA recommendations. The book concludes that enhancing the educational and motivational value of DTCA will require more than a set of recommendations. The results shed light on the pharmaceutical industry’s compliance with both hard and soft regulation. Neither federal recommendations nor industry guidelines resulted in the changes to DTCA envisioned by the FDA. Regulatory action is necessary to ensure that pharmaceutical companies develop advertising campaigns that not only promote their products, but also positively impact the health outcomes of those who read their ads.
Potential Effects of a Ban on Direct-to-Consumer Advertising of New Prescription Drugs
Author: Publisher: DIANE Publishing
ISBN: 1437986633
Category :
Languages : en
Pages : 8
Book Description